Journal article
CD200 ectodomain shedding into the tumor microenvironment leads to NK cell dysfunction and apoptosis
- Abstract:
- The basis of immune evasion, a hallmark of cancer, can differ even when cancers arise from one cell type such as in the human skin keratinocyte carcinomas: basal and squamous cell carcinoma. Here we showed that the basal cell carcinoma tumor initiating cell surface protein CD200, through ectodomain shedding, was responsible for the near absence of NK cells within the basal cell carcinoma tumor microenvironment. In situ, CD200 underwent ectodomain shedding by metalloproteinases MMP3 and MMP11, which released biologically active soluble CD200 into the basal cell carcinoma microenvironment. CD200 bound its cognate receptor on NK cells, to suppress MAPK pathway signaling that in turn blocked indirect (gamma interferon release) and direct cell killing. In addition, reduced ERK phosphorylation relinquished negative regulation of PPARγ regulated gene transcription and lead to membrane accumulation of the Fas/FADD death receptor and its ligand, FasL that resulted in activation-induced apoptosis. Blocking CD200 inhibition of MAPK or PPARγ signaling restored NK cell survival and tumor cell killing, with relevance to many cancer types. Our results thus uncover a paradigm for CD200 as a potentially novel and targetable NK cell specific immune checkpoint, which is responsible for NK cell associated poor outcomes in many cancers
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 14.9MB, Terms of use)
-
- Publisher copy:
- 10.1172/jci150750
Authors
+ Cancer Research UK
More from this funder
- Funder identifier:
- 10.13039/501100000289
- Grant:
- Development fund
+ British Skin Foundation
More from this funder
- Funder identifier:
- 10.13039/501100000296
- Grant:
- 6056i
+ Life Sciences Research Network Wales
More from this funder
- Funder identifier:
- 10.13039/501100014332
- Grant:
- Ser Cymru award
- Publisher:
- American Society for Clinical Investigation
- Journal:
- The Journal of Clinical Investigation More from this journal
- Volume:
- 132
- Issue:
- 21
- Pages:
- e150750
- Article number:
- e150750
- Publication date:
- 2022-09-08
- DOI:
- EISSN:
-
1558-8238
- ISSN:
-
0021-9738
- Language:
-
English
- Keywords:
- Pubs id:
-
1279420
- Local pid:
-
pubs:1279420
- Source identifiers:
-
W4294991249
- Deposit date:
-
2026-04-28
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2022
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record